Senescent cells re ‐engineered to express soluble programmed death receptor‐1 for inhibiting programmed death receptor‐1/programmed death ligand‐1 as a vaccination approach against breast cancer

Cancer Science, EarlyView.
Source: Cancer Science - Category: Cancer & Oncology Authors: Source Type: research